202 related articles for article (PubMed ID: 32629365)
61. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
[TBL] [Abstract][Full Text] [Related]
62. Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram.
Pietrantonio F; Miceli R; Rimassa L; Lonardi S; Aprile G; Mennitto A; Marmorino F; Bozzarelli S; Antonuzzo L; Tamburini E; Morano F; Rossini D; Battaglin F; Baretti M; Berenato R; Formica V; Mosconi S; Petrelli F; Ghidini M; Loupakis F; Spada D; Cinieri S; Beretta G; Falcone A; de Braud F; Cremolini C
Ann Oncol; 2017 Mar; 28(3):555-561. PubMed ID: 27864220
[TBL] [Abstract][Full Text] [Related]
63. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.
Hanna GJ; Grover P; Elliott A; McGrath J; Xiu J; Sukari A; Johnson JM; Wise-Draper T
Clin Cancer Res; 2024 May; 30(10):2225-2232. PubMed ID: 38416410
[TBL] [Abstract][Full Text] [Related]
64. Distant metastasis in adenoid cystic carcinoma of salivary origin.
Spiro RH
Am J Surg; 1997 Nov; 174(5):495-8. PubMed ID: 9374223
[TBL] [Abstract][Full Text] [Related]
65. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis.
Fernández Montes A; López López C; Argilés Martínez G; Páez López D; López Muñoz AM; García Paredes B; Gutiérrez Abad D; Castañón López C; Jiménez Fonseca P; Gallego Plazas J; López Doldán MC; Martínez de Castro E; Sánchez Cánovas M; Tobeña Puyal M; Llorente Ayala B; Juez Martel I; López Flores M; Carmona-Bayonas A
Oncologist; 2019 Aug; 24(8):e687-e695. PubMed ID: 31147489
[TBL] [Abstract][Full Text] [Related]
66. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
[TBL] [Abstract][Full Text] [Related]
67. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
68. Pattern of recurrent disease in major salivary gland adenocystic carcinoma.
Hirvonen K; Bäck L; Saarilahti K; Leivo I; Hagström J; Mäkitie AA
Virchows Arch; 2015 Jul; 467(1):19-25. PubMed ID: 25838077
[TBL] [Abstract][Full Text] [Related]
69. Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
Fang Y; Peng Z; Wang Y; Gao K; Liu Y; Fan R; Zhang H; Xie Z; Jiang W
Oral Oncol; 2022 Jul; 130():105945. PubMed ID: 35662026
[TBL] [Abstract][Full Text] [Related]
70. [Adenoid cystic carcinoma of the salivary glands in patients in the Department of Otolaryngology, Medical Academy in Warsaw (author's transl)].
Osuch J; Osóbka-Morawska A; Sonnenberg Z
Otolaryngol Pol; 1982; 36(1):23-9. PubMed ID: 6285249
[No Abstract] [Full Text] [Related]
71. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
[TBL] [Abstract][Full Text] [Related]
72. Management of adenoid cystic carcinoma of the head and neck: a single-institute study with over 25-year follow-up.
Ishida E; Ogawa T; Rokugo M; Ishikawa T; Wakamori S; Ohkoshi A; Usubuchi H; Higashi K; Ishii R; Nakanome A; Katori Y
Head Face Med; 2020 Jul; 16(1):14. PubMed ID: 32616049
[TBL] [Abstract][Full Text] [Related]
73. Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.
Emerick C; Mariano FV; Vargas PA; Nör JE; Squarize CH; Castilho RM
Crit Rev Oncol Hematol; 2022 Nov; 179():103792. PubMed ID: 35973662
[TBL] [Abstract][Full Text] [Related]
74. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up.
van der Wal JE; Becking AG; Snow GB; van der Waal I
Head Neck; 2002 Aug; 24(8):779-83. PubMed ID: 12203804
[TBL] [Abstract][Full Text] [Related]
75. Outcome of surgery and post-operative radiotherapy for major salivary gland carcinoma: ten year experience from a single institute.
Kaur J; Goyal S; Muzumder S; Bhasker S; Mohanti BK; Rath GK
Asian Pac J Cancer Prev; 2014; 15(19):8259-63. PubMed ID: 25339015
[TBL] [Abstract][Full Text] [Related]
76. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathologic and prognostic factors in adenoid cystic carcinoma of head and neck minor salivary glands: A clinical analysis of 130 cases.
He S; Li P; Zhong Q; Hou L; Yu Z; Huang Z; Chen X; Fang J; Chen X
Am J Otolaryngol; 2017; 38(2):157-162. PubMed ID: 28041635
[TBL] [Abstract][Full Text] [Related]
78. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
79. Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.
Li Y; Ju J; Liu X; Gao T; Wang Z; Ni Q; Ma C; Zhao Z; Ren Y; Sun M
Oncotarget; 2017 Apr; 8(15):24469-24482. PubMed ID: 28160551
[TBL] [Abstract][Full Text] [Related]
80. Survival Outcome of Intermediate-Grade Salivary Gland Carcinoma.
Park GC; Roh JL; Cho KJ; Jung YG; Lee HW; Kim TG; Choi SH; Nam SY; Kim SY
Oncology; 2018; 94(2):125-132. PubMed ID: 29151106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
